Michela De Martino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michela De Martino has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Paolo Dionigi
Department of Surgery, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
11 shared publications - Lorenzo Cobianchi
Unit of General Surgery I, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy
6 shared publications - Tommaso Dominioni
Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy
6 shared publications M. Alessiani
Chirurgia Epatopancreatica, IRCCS Pol. San Matteo e Dipartimento di Scienze Chirurgiche Università di Pavia, Italy
5 shared publicationsM. Doni
5 shared publicationsS. Zonta
5 shared publications
Latest Publications
- 1 October 2015
- Published by SAGE Publications in Surgical Infections
- Vol. 16 (5) , 626-635
Influence of Surgical Technique, Performance Status, and Peritonitis Exposure on Surgical Site Infection in Acute Complicated Diverticulitis: A Matched Case–Control Study
Acute generalized peritonitis secondary to complicated diverticulitis is a life-threatening condition; the standard treatment is surgery. Despite advances in peri-operative care, this condition is accompanied by a high peri-operative complication rate (22%-25%). No definitive evidence is available to recommend a preferred surgical technique in patients with Hinchey stage III/IV disease. A matched case-control study enrolling patients from four surgical units at Italian university hospital was planned to assess the most appropriate surgical treatment on the basis of patient performance status and peritonitis exposure, with the aim of minimizing the surgical site infection (SSI). A series of 1,175 patients undergoing surgery for Hinchey III/IV peritonitis in 2003-2013 were analyzed. Cases (n=145) were selected from among those patients who developed an SSI. control ratio was 1:3. Cases and control groups were matched by age, gender, body mass index, and Hinchey grade. We considered three surgical techniques: T1=Hartman's procedure; T2=sigmoid resection, anastomosis, and ileostomy; and T3=sigmoid resection and anastomosis. Six scoring systems were analyzed to assess performance status; subsequently, patients were divided into low, mild, and high risk (LR, MR, HR) according to the system producing the highest area under the curve. We classified peritonitis exposition as P1=24 h. Univariable and multivariable analyses were performed. The Apgar scoring system defined the risk groups according to performance status. Lowest SSI risk was expected when applying T3 in P1 (OR=0.22), P2 (OR=0.5) for LR and in P1 (OR=0.63) for MR; T2 in P2 (OR=0.5) in LR and in P1 (OR=0.61) in MR; T1 in P3 (OR=0.56) in LR; in P2 (OR=0.63) and P3 (OR=0.54) in MR patients, and in each P subgroup (OR=0.93;0.97;1.01) in HR. Pre-operative assessment based on Apgar scoring system integrated with peritonitis exposure in complicated diverticulitis may offer a ready-to-use tool for reducing SSI-related complications and applying appropriate treatment, reducing the need for disabling ostomy.
- 1 October 2015
- Published by SAGE Publications in Surgical Infections
- Vol. 16 (5) , 626-635
Influence of Surgical Technique, Performance Status, and Peritonitis Exposure on Surgical Site Infection in Acute Complicated Diverticulitis: A Matched Case–Control Study
Acute generalized peritonitis secondary to complicated diverticulitis is a life-threatening condition; the standard treatment is surgery. Despite advances in peri-operative care, this condition is accompanied by a high peri-operative complication rate (22%-25%). No definitive evidence is available to recommend a preferred surgical technique in patients with Hinchey stage III/IV disease. A matched case-control study enrolling patients from four surgical units at Italian university hospital was planned to assess the most appropriate surgical treatment on the basis of patient performance status and peritonitis exposure, with the aim of minimizing the surgical site infection (SSI). A series of 1,175 patients undergoing surgery for Hinchey III/IV peritonitis in 2003-2013 were analyzed. Cases (n=145) were selected from among those patients who developed an SSI. control ratio was 1:3. Cases and control groups were matched by age, gender, body mass index, and Hinchey grade. We considered three surgical techniques: T1=Hartman's procedure; T2=sigmoid resection, anastomosis, and ileostomy; and T3=sigmoid resection and anastomosis. Six scoring systems were analyzed to assess performance status; subsequently, patients were divided into low, mild, and high risk (LR, MR, HR) according to the system producing the highest area under the curve. We classified peritonitis exposition as P1=24 h. Univariable and multivariable analyses were performed. The Apgar scoring system defined the risk groups according to performance status. Lowest SSI risk was expected when applying T3 in P1 (OR=0.22), P2 (OR=0.5) for LR and in P1 (OR=0.63) for MR; T2 in P2 (OR=0.5) in LR and in P1 (OR=0.61) in MR; T1 in P3 (OR=0.56) in LR; in P2 (OR=0.63) and P3 (OR=0.54) in MR patients, and in each P subgroup (OR=0.93;0.97;1.01) in HR. Pre-operative assessment based on Apgar scoring system integrated with peritonitis exposure in complicated diverticulitis may offer a ready-to-use tool for reducing SSI-related complications and applying appropriate treatment, reducing the need for disabling ostomy.
- Open Access
- 6 June 2014
- Published by Wiley in BJU International
- Vol. 115 (5) , 722-727
Adjuvant cisplatin‐based combined chemotherapy for lymph node ( LN )‐positive urothelial carcinoma of the bladder ( UCB ) after radical cystectomy ( RC ): a retrospective international study of >1500 patients
Objective: To compare outcomes of patients with lymph node ( LN )‐positive urothelial carcinoma of the bladder ( UCB ) treated with or without cisplatin‐based combined adjuvant chemotherapy ( AC ) after radical cystectomy ( RC ). Patients and Methods: We retrospectively analysed 1523 patients with LN ‐positive UCB , who underwent RC with bilateral pelvic LN dissection. All patients had no evidence of disease after RC . AC was administered within 3 months. Competing‐risks models were applied to compare UCB ‐related mortality. Results: Of the 1523 patients, 874 (57.4%) received AC . The cumulative 1‐, 2‐ and 5‐year UCB ‐related mortality rates for all patients were 16%, 36% and 56%, respectively. Administration of AC was associated with an 18% relative reduction in the risk of UCB ‐related death (subhazard ratio 0.82, P = 0.005). The absolute reduction in mortality was 3.5% at 5 years. The positive effect of AC was detectable in patients aged ≤70 years, in women, in pT3 –4 disease, and in those with a higher LN density and lymphovascular invasion. This study is limited by its retrospective and non‐randomised design, selection bias, the absence of central pathological review and lack in standardisation of LN dissection and cisplatin‐based protocols. Conclusion: AC seems to reduce UCB ‐related mortality in patients with LN ‐positive UCB after RC . Younger patients, women and those with high‐risk features such as pT3 –4 disease, a higher LN density and lymphovascular invasion appear to benefit most. Appropriately powered prospective randomised trials are necessary to confirm these findings.
- 6 June 2014
- Published by Wiley in BJU International
- Vol. 115 (5) , 722-727
Open AccessAdjuvant cisplatin‐based combined chemotherapy for lymph node ( LN )‐positive urothelial carcinoma of the bladder ( UCB ) after radical cystectomy ( RC ): a retrospective international study of >1500 patients
Objective: To compare outcomes of patients with lymph node ( LN )‐positive urothelial carcinoma of the bladder ( UCB ) treated with or without cisplatin‐based combined adjuvant chemotherapy ( AC ) after radical cystectomy ( RC ). Patients and Methods: We retrospectively analysed 1523 patients with LN ‐positive UCB , who underwent RC with bilateral pelvic LN dissection. All patients had no evidence of disease after RC . AC was administered within 3 months. Competing‐risks models were applied to compare UCB ‐related mortality. Results: Of the 1523 patients, 874 (57.4%) received AC . The cumulative 1‐, 2‐ and 5‐year UCB ‐related mortality rates for all patients were 16%, 36% and 56%, respectively. Administration of AC was associated with an 18% relative reduction in the risk of UCB ‐related death (subhazard ratio 0.82, P = 0.005). The absolute reduction in mortality was 3.5% at 5 years. The positive effect of AC was detectable in patients aged ≤70 years, in women, in pT3 –4 disease, and in those with a higher LN density and lymphovascular invasion. This study is limited by its retrospective and non‐randomised design, selection bias, the absence of central pathological review and lack in standardisation of LN dissection and cisplatin‐based protocols. Conclusion: AC seems to reduce UCB ‐related mortality in patients with LN ‐positive UCB after RC . Younger patients, women and those with high‐risk features such as pT3 –4 disease, a higher LN density and lymphovascular invasion appear to benefit most. Appropriately powered prospective randomised trials are necessary to confirm these findings.
- 1 September 2012
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (7) , 2029-2032
Development of a Standardized Model for Liver Failure in Pigs: Anatomopathophysiologic Findings After Extended Liver Resection
- 1 September 2012
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (7) , 2029-2032
Development of a Standardized Model for Liver Failure in Pigs: Anatomopathophysiologic Findings After Extended Liver Resection
- Open Access
- 31 January 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (5) , 904-908
Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
Background: Methods: Results: Conclusion:
- 31 January 2012
- Published by Springer Nature in British Journal of Cancer
- Vol. 106 (5) , 904-908
Open AccessSerum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
Background: Methods: Results: Conclusion:
- 1 January 2012
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 17 (4) , 140-143
Selective use of extended criteria deceased liver donors with anatomic variations
An ongoing shortage of organs for liver transplantation has led surgeons to continually modify criteria for organ acceptance, which are now defined as extended criteria. The organ shortage becomes more problematic in retransplantation, in which the use of a limited resource such as a liver graft with anatomic variation must be weighed against the risk of a more difficult operation. We report 2 peculiar anatomic variations discovered in deceased donors for whole liver transplantation and confirmed at the back table: 1 with a huge biliary enlargement of the common hepatic duct and 1 with a celiac trunk aneurysm. In the first variation, any potential biliary reconstruction was thought to be at high risk of difficult outflow. The vascular anomaly did not preclude successful performance of a liver retransplantation. We briefly report the use of 2 liver grafts from deceased donors with rare anatomic variations, which is relevant to increasing the liver donor pool. To the best of our knowledge this is the first report of this biliary anomaly. In certain specific settings, strategies based on the appropriate donor-recipient match have allowed the use of grafts that otherwise would have been discarded due to celiac aneurysm.
- 1 January 2012
- Published by International Scientific Information, Inc. in Annals of Transplantation
- Vol. 17 (4) , 140-143
Selective use of extended criteria deceased liver donors with anatomic variations
An ongoing shortage of organs for liver transplantation has led surgeons to continually modify criteria for organ acceptance, which are now defined as extended criteria. The organ shortage becomes more problematic in retransplantation, in which the use of a limited resource such as a liver graft with anatomic variation must be weighed against the risk of a more difficult operation. We report 2 peculiar anatomic variations discovered in deceased donors for whole liver transplantation and confirmed at the back table: 1 with a huge biliary enlargement of the common hepatic duct and 1 with a celiac trunk aneurysm. In the first variation, any potential biliary reconstruction was thought to be at high risk of difficult outflow. The vascular anomaly did not preclude successful performance of a liver retransplantation. We briefly report the use of 2 liver grafts from deceased donors with rare anatomic variations, which is relevant to increasing the liver donor pool. To the best of our knowledge this is the first report of this biliary anomaly. In certain specific settings, strategies based on the appropriate donor-recipient match have allowed the use of grafts that otherwise would have been discarded due to celiac aneurysm.
- 14 April 2011
- Vol. 28 (2) , 132-4
[Mesenchymal stromal cells injection reduces acute rejection damage in a rat experimental model of kidney transplantation].
- 14 April 2011
- Vol. 28 (2) , 132-4
[Mesenchymal stromal cells injection reduces acute rejection damage in a rat experimental model of kidney transplantation].
- 1 May 2010
- Published by Elsevier in Transplantation Proceedings
- Vol. 42 (4) , 1331-1335
Mesenchymal Stem Cells Infusion Prevents Acute Cellular Rejection in Rat Kidney Transplantation
- 1 May 2010
- Published by Elsevier in Transplantation Proceedings
- Vol. 42 (4) , 1331-1335
Mesenchymal Stem Cells Infusion Prevents Acute Cellular Rejection in Rat Kidney Transplantation
- 1 March 2009
- Published by Elsevier in European Urology Supplements
- Vol. 8 (4) , 297
706 CA9 GENE SINGLE NUCLEOTIDE POLYMORPHISMS PREDICT PROGNOSIS AND TREATMENT RESPONSE OF METASTATIC RENAL CELL CARCINOMA
- 1 March 2009
- Published by Elsevier in European Urology Supplements
- Vol. 8 (4) , 297
706 CA9 GENE SINGLE NUCLEOTIDE POLYMORPHISMS PREDICT PROGNOSIS AND TREATMENT RESPONSE OF METASTATIC RENAL CELL CARCINOMA